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Summary
Background—The eastern Mediterranean region is comprised of 22 countries: Afghanistan, 
Bahrain, Djibouti, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Pakistan, 
Palestine, Qatar, Saudi Arabia, Somalia, Sudan, Syria, Tunisia, the United Arab Emirates, and 
Yemen. Since our Global Burden of Disease Study 2010 (GBD 2010), the region has faced unrest 
as a result of revolutions, wars, and the so-called Arab uprisings. The objective of this study was to 
present the burden of diseases, injuries, and risk factors in the eastern Mediterranean region as of 
2013.
Methods—GBD 2013 includes an annual assessment covering 188 countries from 1990 to 2013. 
The study covers 306 diseases and injuries, 1233 sequelae, and 79 risk factors. Our GBD 2013 
analyses included the addition of new data through updated systematic reviews and through the 
contribution of unpublished data sources from collaborators, an updated version of modelling 
software, and several improvements in our methods. In this systematic analysis, we use data from 
GBD 2013 to analyse the burden of disease and injuries in the eastern Mediterranean region 
specifically.
Findings—The leading cause of death in the region in 2013 was ischaemic heart disease (90·3 
deaths per 100 000 people), which increased by 17·2% since 1990. However, diarrhoeal diseases 
were the leading cause of death in Somalia (186·7 deaths per 100 000 people) in 2013, which 
decreased by 26·9% since 1990. The leading cause of disability-adjusted life-years (DALYs) was 
ischaemic heart disease for males and lower respiratory infection for females. High blood pressure 
was the leading risk factor for DALYs in 2013, with an increase of 83·3% since 1990. Risk factors 
for DALYs varied by country. In low-income countries, childhood wasting was the leading cause 
of DALYs in Afghanistan, Somalia, and Yemen, whereas unsafe sex was the leading cause in 
Djibouti. Non-communicable risk factors were the leading cause of DALYs in high-income and 
middle-income countries in the region. DALY risk factors varied by age, with child and maternal 
malnutrition affecting the younger age groups (aged 28 days to 4 years), whereas high bodyweight 
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and systolic blood pressure affected older people (aged 60–80 years). The proportion of DALYs 
attributed to high body-mass index increased from 3·7% to 7·5% between 1990 and 2013. Burden 
of mental health problems and drug use increased. Most increases in DALYs, especially from non-
communicable diseases, were due to population growth. The crises in Egypt, Yemen, Libya, and 
Syria have resulted in a reduction in life expectancy; life expectancy in Syria would have been 5 
years higher than that recorded for females and 6 years higher for males had the crisis not 
occurred.
Interpretation—Our study shows that the eastern Mediterranean region is going through a 
crucial health phase. The Arab uprisings and the wars that followed, coupled with ageing and 
population growth, will have a major impact on the region’s health and resources. The region has 
historically seen improvements in life expectancy and other health indicators, even under stress. 
However, the current situation will cause deteriorating health conditions for many countries and 
for many years and will have an impact on the region and the rest of the world. Based on our 
findings, we call for increased investment in health in the region in addition to reducing the 
conflicts.
Funding—Bill & Melinda Gates Foundation.
Introduction
The eastern Mediterranean region is comprised of 22 countries: Afghanistan, Egypt, 
Bahrain, Djibouti, Iraq, Iran, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Pakistan, 
Palestine, Qatar, Saudi Arabia, Somalia, Sudan, Syria, Tunisia, the United Arab Emirates, 
and Yemen. The region has a population of about 583 million people.1 Countries in the 
eastern Mediterranean region vary substantially in their gross domestic product, 
sociodemographic profiles, health indicators, and health system capacities and coverage.2,3
The political and economic situation in the region since 2010 has suffered from continued 
unrest and the Arab uprisings. Revolutions and changes in government occurred in Egypt, 
Libya, Tunisia, and Yemen. A civil war is devastating Syria, and disturbances are common 
in Afghanistan, Bahrain, Iraq, Palestine, and Somalia. As a result, hundreds of thousands of 
civilians have been forced to flee and seek refuge.
In this Article, we present the burden of diseases, injuries, and risk factors in the eastern 
Mediterranean region from 1990 to 2013, with the aim to show the impact of war and unrest 
on the health of people in the region as of the end of 2013.
Methods
Study overview
The Global Burden of Disease Study 2013 (GBD 2013) includes an annual assessment 
covering 188 countries from 1990 to 2013. It covers 306 diseases and injuries, 1233 
sequelae, and 79 risk factors. Detailed descriptions of the method and approach of GBD 
2013 have been published elsewhere.4–7 Key changes in the methods from GBD 2010 are 
the inclusion of new data through updated systematic reviews and the contribution of 
unpublished data sources from various collaborators; the use of a counterfactual approach 
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for estimating causes of diarrhoea and pneumonia; elaboration of the sequelae list to include 
asymptomatic states; use of more detailed nature of injury codes (N-codes); improvements 
to the Bayesian meta-regression method; increased simulation size for comorbidity; 
estimation of the prevalence of injuries by cohort; and use of a new method to estimate the 
distribution of mild, moderate, and severe anaemia by cause. In this systematic analysis, we 
use data from GBD 2013 to analyse the burden of disease and injuries in the eastern 
Mediterranean region specifically. We report 95% uncertainty intervals for each value in our 
analysis.
Mortality estimation
We generated child mortality rates and adult mortality rates under the influence of natural 
disasters and armed conflicts as previously described.7 Because of ongoing unrest and war, 
some datapoints needed for our analyses were not available. A list of all datapoints used in 
this study are available on our Global Health Data Exchange web page. When data were 
unavailable, we relied on our ensemble modelling techniques to generate the estimates using 
other available variables and the information for neighbouring countries or countries with a 
similar health profile in the region. We used six different modelling strategies for the 240 
causes of death using our cause-of-death ensemble model for causes with sufficient 
information. We estimated national time series from 1950 to 2013 for gross domestic 
product, educational attainment, tobacco prevalence, and obesity. For mortality rates of 
children younger than 5 years, we analysed all survey, census, sample registration, and vital 
registration sources. Wherever possible, we analysed microdata from surveys and censuses 
with updated methods for child mortality. We corrected for bias in different sources in 
specific countries. For adult mortality, we identified all available vital registration data, 
sibling history survey data, sample registration data, and household recall of deaths. We 
assessed vital registration data for completeness and analysed sibling history data to account 
for survivor bias, zero-surviving sibships, and recall bias. We used spatiotemporal regression 
and Gaussian process regression to synthesise all measurements of mortality. We used UN 
population estimates that account for migration in our analyses. Moreover, we applied 
mortality shocks based on multiple reports to our analyses.
Effects of risk factors on disease burden
We used the comparative risk assessment approach to evaluate how much of the burden of 
disease observed in a given year can be attributed to past exposure to a risk factor.7 We 
estimated attributable burden by comparing observed health outcomes with outcomes that 
would have been observed if an alternative or counterfactual level of exposure had taken 
place in the past. We used the exposure level that minimises risk for the population, termed 
the theoretical minimum risk exposure level. We avoided double counting in the presentation 
of overall results by computing the overlap for joint risk distributions: behavioural risks 
alone; environmental or occupational risks alone; metabolic risks alone; behavioural and 
environmental or occupational risks together; behavioural and metabolic risks together; 
environmental or occupational and metabolic risks together; and behavioural, environmental 
or occupational, and metabolic risks together.
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Disaggregation
We cross-tabulated the quantiles of disability-adjusted life-years (DALYs) by quintiles of 
annual DALY increase from 1990 to 2013 to show rates of DALY increase by burden. We 
divided the region into three categories according to the gross national income (GNI) per 
capita. The first category represents the low-income countries with an average GNI per 
capita of US$523·3 On the opposite end of the spectrum are oil-rich, high-income countries 
with an average GNI per capita of $39 688. The nations that lie in between are the middle-
income countries with an average GNI per capita of $3251, which can be further subdivided 
into lower-middle-income and upper-middle-income countries. Low-income countries were 
Afghanistan, Djibouti, Somalia, and Yemen. Middle-income countries were Egypt, Iran, 
Iraq, Jordan, Lebanon, Libya, Morocco, Pakistan, Palestine, Sudan, Syria, and Tunisia. 
High-income countries were Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United 
Arab Emirates.
Role of the funding source
The funder of the study had no role in study design, data collection, data analysis, data 
interpretation, or writing of the report. The corresponding author had full access to all the 
data in the study and had final responsibility to submit the paper.
Results
The leading cause of death in the eastern Mediterranean region in 2013 was ischaemic heart 
disease (90·3 deaths per 100 000 people).8 It surpassed both diarrhoeal diseases and lower 
respiratory infections as the leading cause of death in 1990, increasing by 17·2%. There was 
a shift in main causes of death from communicable to non-communicable diseases in the 
region. Causes of death and their rates of change varied by country.8 For example, diarrhoeal 
disease was the leading cause of death in Somalia and accounted for 186·7 deaths per 100 
000 people in 2013, a decrease of 26·9% from 1990.9 All countries observed an increase in 
life expectancy and healthy life expectancy since 1990, although at different rates (appendix 
pp 7–8). Afghanistan had the lowest life expectancy and healthy life expectancy (56·5 years 
vs 49·0 years for men, 56·0 years vs 48·8 years for women, respectively), whereas Qatar had 
the highest (81·2 years vs 69·2 years for men, 83·1 years vs 69·5 years for women, 
respectively). Lebanon had a higher increase in healthy life expectancy than life expectancy. 
Global life expectancy for both sexes increased from 65·3 years in 1990, to 71·5 years in 
2013.4
There was a change in causes of years of life lost (YLLs) from 1990 to 2013 in all countries 
(appendix p 9). Overall, regional YLLs decreased from 45 312 years per 100 000 people in 
1990 to about 24 160 years per 100 000 people in 2013.8 Cardiovascular diseases, 
neoplasms, diabetes, chronic kidney disease, and transport injuries increased, especially in 
high-income and middle-income countries in the region, whereas neonatal disorders, 
diarrhoeal diseases, and lower respiratory infections decreased. HIV/AIDS and tuberculosis 
were large contributors to YLLs in 2013 in Djibouti. War was a large contributor to YLLs in 
Syria in 2013 (38·1% of total YLLs).8
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Overall, regional years lived with disability (YLDs) increased from 9526 years per 100 000 
people in 1990 to about 10057 years per 100 000 people in 2013.8 Musculoskeletal disorders 
and mental disorders and substance abuse were major contributors to YLDs in 2013 and had 
the highest increase (appendix p 10). Nutritional deficiencies (mainly iron-deficiency 
anaemia) decreased in the region overall, but remained a large burden in low-income 
countries. For example, nutritional deficiencies remained one of the leading causes of YLDs 
in Yemen although the YLDs per 100 000 people decreased slightly by 2% from 1990.8
Overall, regional DALYs decreased from 54 838 years per 100 000 people in 1990 to about 
34 217 years per 100 000 people in 2013. DALYs vary disproportionately by age and sex. 
Children younger than 5 years contributed to about 33% of total DALYs with a rate of 94 
884 years per 100 000 people, compared with 34 217 years per 100 000 people for the 
general population.8 Ischaemic heart disease was the leading cause of DALYs in the region 
in 2013 in males and when data for both sexes were combined, whereas diarrhoeal diseases 
were the leading cause in 1990 (table 1). Lower respiratory infection was the leading cause 
of DALYs for females. Causes of DALYs varied by income; lower respiratory infection was 
the leading cause of DALYs in low-income countries (appendix p 15), ischaemic heart 
disease in middle-income countries (appendix p 16), and road injuries in high-income 
countries (appendix p 17). Causes of DALYs and their change from 1990 by country varied 
widely (appendix p 11). Causes of DALYs varied by age. For example, DALYs for mental 
health peaked in early adulthood and declined with age, whereas DALYs for cardiovascular 
diseases and neoplasms increased with age (appendix p 1). Different patterns of DALYs 
were observed in different income levels (appendix pp 12–14).
High blood pressure was the leading risk factor for DALYs in 2013, which increased by 
83·3% from 1990 (from 8·5 million to 16·1 million DALYs; table 2;8 however, the number 
of DALYs per 100 000 people increased by only 14%. High blood pressure increased from 
the fifth highest cause of DALYs in 1990 to first in 2013. Risk factors for DALYs varied by 
country, with childhood wasting as the leading cause in Somalia, Afghanistan, and Yemen, 
whereas unsafe sex was the leading cause of DALYs in Djibouti. Conversely, non-
communicable disease risk factors were the leading cause of DALYs in high-income 
countries and middle-income countries (figure 1). DALY risk factors varied by age; child 
malnutrition and suboptimal breastfeeding affected the younger age groups (aged 7 days to 4 
years) and high bodyweight and systolic blood pressure affected the older age groups (aged 
60–80 years; appendix p 2).
The annualised rates of change for DALY risk factors by burden for the region, low-income, 
middle-income, and high-income countries are shown in the appendix (pp 3–6). DALYs per 
100 000 people attributed to high body-mass index increased by 28% from 1990 to 2013 
(from 1961 years per 100 000 people to 2506 years per 100 000 people) and accounted for 
over 7·3% of total DALYs.8 For high-income countries, high fasting plasma glucose, high 
body-mass index, alcohol use, and drug use accounted for the highest annual increase with a 
high DALYs burden.
Decomposition tables for the impact of ageing and population growth on the changes in 
DALYs from communicable diseases, non-communicable diseases, and injuries for the 
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region are shown in table 3, and in the appendix (pp 18–21) for low-income, middle-income, 
and high-income countries. DALYs caused by non-communicable diseases and injuries 
increased (mainly because of population growth), whereas DALYs caused by communicable 
diseases decreased, although the actual rates of DALYs decreased for all risk factors (table 
3).
Projected life expectancy using figures from 2009 until 2013, based on the trends observed 
from 1990 to 2008 compared with observed life expectancy from GBD 2013 are shown in 
figures 2 and 3. From 1990 to 2010, Egypt, Libya, Syria, and Yemen had a steady increase 
in life expectancy of about 0·25 years per year, with a slightly higher increase in females 
(about 0·3 years) than in males. However, Egypt, Tunisia, and Yemen have lost about 0·25 
years of life expectancy due to the uprising that began in 2010. When comparing observed 
life expectancy to expected life expectancy if no crisis had occurred, we found a large 
decrease in life expectancy in Libya of more than 9 years for males and 6 years for females. 
Conversely, a steady decrease in life expectancy was observed in Syria because of the 
continuing war. Therefore, between 1990 and 2013 life expectancy for Syria would have 
been 6 years higher than observed for males and 5 years higher for females had the crisis not 
happened. Moreover, our analyses showed that several countries in the region have 
experienced a slow-down in lowering infant mortality rate. For example, in Syria the 
annualised rate of reduction in infant mortality between 2010 to 2013 was –9·1%, in sharp 
contrast with the rate of decrease of 6·0% before 2010.9
Discussion
The eastern Mediterranean region is facing numerous health challenges as a result of 
previous wars, recent revolutions, and the wars that followed, and of ageing and population 
growth. Life expectancy at birth in the region increased from 65 years in 1990 to 71 years in 
2013, with an annual increase of about 0·26 years. However, according to our study, the 
situation has resulted in deteriorating health conditions for many countries that are 
threatening these gains and will have an impact on the region and worldwide. Hence, on the 
basis of our results, we call for increased investment in health in the region, and suppression 
of the conflicts.
Our study showed a rapid increase in the burden of mental and drug-use disorders in the 
region. Unfortunately, the rise in burden of mental health problems has not been met with 
investment in prevention by most countries in the region, with few exceptions, such as 
Lebanon and Qatar.10,11 Mental health is not viewed as a major burden by many countries 
and is not discussed in the agendas of many international agencies and health ministries. We 
hope that our findings will shed light and lead to more attention by global and regional 
health agencies to tackle this rising burden.
Similarly, the rapid rise in non-communicable diseases is alarming. Diabetes, for example, is 
a heavy burden on many countries, with deaths increasing from 12 to 19 per 100 000 people. 
One study12 showed a high cost of diabetes in Saudi Arabia. These trends, irrespective of 
their cause, will lead to a strain on finances and human resources in a region where they are 
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already scarce. The prevention and control of risk factors associated with non-communicable 
diseases should be a priority for the region.
The spread of communicable diseases in the eastern Mediterranean region is of concern. The 
Hajj annual pilgrimage presents a challenge to health planners. The mass gathering for Hajj 
has led to several outbreaks of infectious disease such as meningitis and polio in Saudi 
Arabia and other countries.13 Moreover, the gathering in Iraq for Ashura, a day of mass 
mourning, has the same potential for the spread of disease.14 In most of these countries, 
kissing is a normal way of greeting people, and sharing food and social congregations are 
common. This cultural behaviour has complicated efforts to control Middle East respiratory 
syndrome (MERS) outbreaks in Saudi Arabia and its spread to other countries.15 
Containment and control of emerging diseases and infections in the eastern Mediterranean 
region is a national interest for all countries.
Our study showed a rise in the burden of disease due to illicit drugs in the region. Several 
studies have reported that, during stress, individuals might engage in risky behaviours.16 
Unfortunately, the response of many countries has been law enforcement measures and strict 
punishment.17 The region is in need of comprehensive socioculturally appropriate 
approaches towards education, prevention, and early identification and treatment.
Road-traffic injuries are the leading cause of DALYs in men in high-income countries 
throughout the region, and rank increasingly higher in low-income and middle-income 
countries than in previous years. Unfortunately, many countries in the region have yet to 
fully implement policies and legislation conducive to road safety, and need to strengthen 
their trauma care systems.18
One of the main challenges and threats for the region is the environment. Most countries in 
the region are facing water shortages due to population pressure, increasing water demand, 
and natural climate variability. Moreover, climate change has resulted in increased 
temperatures in the region, and a major part of the eastern Mediterranean region is projected 
to be uninhabitable in the next 50–80 years.19 Additionally, most countries in the region are 
not food sufficient and rely heavily on imports to meet growing demands. Development of a 
plan to address these issues is crucial for the region and the world, because they will affect 
the stability and future of the region.
Unrest, civil conflicts, and wars have had a big impact on the burden of disease in the 
eastern Mediterranean region. However, the long-term impact of the unrest is not yet known. 
The region is losing its health talents, as many medical doctors and health professionals 
leave conflict areas in search of a better life elsewhere.20 Moreover, historically high rates of 
unemployment in the region have caused many other people to seek work elsewhere.
Many countries in the region are facing other health challenges that they are not equipped 
for. For example, the conflict in Syria has resulted in millions of individuals being displaced 
internally and millions of others forced to seek refuge in neighbouring countries. Only when 
an influx of Syrian refugees into Europe occurred did this crisis receive widespread media 
coverage. There is a need for long-term planning to improve the health of and stabilise the 
region.
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The infrastructure in several of these countries has been destroyed because of war. Water and 
sanitation will pose major challenges until proper reconstruction is achieved. Unfortunately, 
these effects will lead to an increased rate of disease spread and outbreaks, which must be 
properly controlled. Moreover, investment in health information systems in the region is 
urgently needed. This investment should be a priority for countries and donors once the 
political situation improves.
Our study showed that many of the health gains achieved by countries in the region are at 
risk of slowing down. In fact, infant mortality has risen in some countries. It is sad to see 
that Syria, a country with a good performance in reducing child mortality in the past, saw a 
rise from 2010 to 2013. Syria is falling behind countries in sub-Saharan Africa when it 
comes to the rate of change in infant mortality.
The political situation in the region continues to be uncertain; since 2013, the wars in Syria 
and Libya have escalated, and a war has started in Yemen. In some areas, residents are 
facing starvation and the public health and medical systems are about to collapse. Moreover, 
wars and unrest in Afghanistan, Iraq, Palestine, and Somalia have continued or re-emerged, 
and for many people in these countries, survival is the main challenge, not health. The 
eastern Mediterranean region is facing several health challenges at a time of uncertainty, and 
the countries in this region are struggling to meet these challenges.
Events in the past 5 years have shown that the wellbeing of people in the eastern 
Mediterranean region crosses beyond its borders, as exemplified by the spread of MERS to 
South Korea and the outbreak of infectious diseases in refugee camps in Lebanon and 
Jordan. A healthy eastern Mediterranean region is a politically stable eastern Mediterranean 
region, one from which the whole world will benefit. Based on our findings, we call for 
stepping up efforts at the regional and local levels to improve health, identify barriers to 
scaling up health promotion and disease prevention services, and to stabilise the region.
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Research in context
Evidence before this study
The Global Burden of Disease Study 2010 (GBD 2010) became available in 2012. GBD 
2010 reported on disability-adjusted life-years (DALYs), health-adjusted life expectancy, 
and 67 risks and risk clusters by 21 world regions and 188 countries.
GBD 2010 covered 20 age and sex groups.
Added value of this study
GBD 2013 includes an annual assessment covering 188 countries, from 1990 to 2013. It 
covers 306 diseases and injuries, 1233 sequelae, and 79 risk factors. GBD 2013 included 
key methodological differences from GBD 2010, which were inclusion of new data 
through updated systematic reviews and through the contribution of unpublished data 
sources from many collaborators; use of a counterfactual approach for estimating 
diarrhoea and pneumonia causes; elaboration of the sequelae list to include asymptomatic 
states; use of more detailed nature of injury codes (N-codes); improvements to the 
Bayesian meta-regression method; increased simulation size for comorbidity; estimation 
of the prevalence of injuries by cohort; and use of a new method to estimate the 
distribution of mild, moderate, and severe anaemia by cause. This study provides an 
overview of the comprehensive burden of diseases and risk factors for the eastern 
Mediterranean region.
Implications of all the available evidence
The eastern Mediterranean region is facing numerous health challenges, as a result of 
previous wars, revolutions, the wars that followed, and ageing and population growth. 
These challenges will have a major impact on health outcomes and available resources. 
The region has historically seen improvements in life expectancy and other health 
indicators even under stress. However, according to our study, the current situation has 
resulted in deteriorating health conditions for many countries that are threatening these 
gains and will have an impact on the region and the rest of the world. On the basis of our 
data, we call for increased investment in health in the region and the end of ongoing 
conflicts.
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Figure 1. DALYs attributed to risk factors in countries of the eastern Mediterranean region, 
1990 and 2013
DALYs=disability-adjusted life-years.
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Figure 2. Projected versus observed life expectancy at birth of males in Egypt, Libya, Syria, 
Tunisia, and Yemen, 2000–13
GBD=Global Burden of Disease.
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Figure 3. Projected versus observed life expectancy at birth of females in Egypt, Libya, Syria, 
Tunisia, and Yemen, 2000–13
GBD=Global Burden of Disease.
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Table 1
Top ten causes of disability-adjusted life-years (DALYs) for the eastern Mediterranean 
region by sex; 1990, 2005, and 2013
1990 2005 2013
Males
1 Diarrhoeal diseases 10·7% (9·1–12·2) Lower respiratory infections 6·7% (5·6–
8)
Ischaemic heart disease 6·7% (5·9–7·6)
2 Lower respiratory infections 10·3% (8·9–11·6) Diarrhoeal diseases 5·9% (4·7–7·1) Lower respiratory infections 5·8% (4·8–
6·9)
3 Preterm birth complications 7·6% (6–9·9) Preterm birth complications 5·8% (4·6–
7·7)
Preterm birth complications 5·2% (3·9–
6·8)
4 Congenital anomalies 4·7% (3·6–6·7) Ischaemic heart disease 5·6% (5–6·3) Diarrhoeal diseases 4·5% (3·5–5·7)
5 Neonatal encephalopathy due to birth asphyxia 
and trauma 3·9% (2·8–5·1)
Road injuries 4·2% (3·8–4·7) Road injuries 4·5% (4·0–5·0)
6 Ischaemic heart disease 3·9% (3·4–4·3) Congenital anomalies 4·1% (3·2–5·8) Congenital anomalies 4·0% (3·3–5·1)
7 Road injuries 3·1% (2·8–4·1) Neonatal encephalopathy due to birth 
asphyxia and trauma 4% (2·5–5·5)
Neonatal encephalopathy due to birth 
asphyxia and trauma 3·7% (2·5–5)
8 Cerebrovascular disease 2·7% (2·3–3·1) Cerebrovascular disease 3·1% (2·7–3·7) Cerebrovascular disease 3·5% (3–4·1)
9 Other neonatal disorders 2·6% (1·7–4·0) Low back and neck pain 2·7% (2·0–3·6) Low back and neck pain 3·4% (2·5–4·4)
10 Meningitis 2·3% (1·6–3·3) Chronic obstructive pulmonary disease 
2·1% (1·9–2·5)
Diabetes mellitus 2·5% (2·2–2·8)
Females
1 Diarrhoeal diseases 12·4% (10·4–14·3) Lower respiratory infections 7·4% (6–9) Lower respiratory infections 6·4% (5·2–
7·6)
2 Lower respiratory infections 11·3% (9·7–12·9) Diarrhoeal diseases 6·7% (5·3–8) Ischaemic heart disease 5·5% (4·4–6·4)
3 Preterm birth complications 6·7% (5·4–8·5) Preterm birth complications 5·2% (4–
6·6)
Diarrhoeal diseases 5·1% (3·9–6·5)
4 Congenital anomalies 5·0% (3·6–6·5) Ischaemic heart disease 4·8% (3·9–5·4) Preterm birth complications 4·7% (3·5–
5·9)
5 Ischaemic heart disease 3·4% (2·7–3·9) Congenital anomalies 4·2% (3·1–5·8) Congenital anomalies 4·1% (3·2–5·1)
6 Neonatal encephalopathy due to birth asphyxia 
and trauma 3·3% (2·3–4·4)
Cerebrovascular disease 3·6% (2·9–4·1) Cerebrovascular disease 4% (3·2–4·7)
7 Cerebrovascular disease 2·9% (2·4–3·3) Neonatal encephalopathy due to birth 
asphyxia and trauma 3·5% (2·5–4·7
Low back and neck pain 3·9% (3·0–4·9)
8 Other neonatal disorders 2·4% (1·6–3·6) Low back and neck pain 3·1% (2·3–3·9) Depressive disorders 3·4% (2·4–4·7)
9 Iron-deficiency anaemia 2·4% (1·8–3·1) Depressive disorders 2·8% (2·0–3·8) Neonatal encephalopathy due to birth 
asphyxia and trauma 3·3% (2·2–4·6)
10 Tuberculosis 2·2% (1·7–2·6) Iron-deficiency anaemia 2·6% (2·0–3·5) Diabetes mellitus 2·9% (2·5–3·2)
Total
1 Diarrhoeal diseases 11·5% (10·1–12·9) Lower respiratory infections 7·1% (5·9–
8·3)
Ischaemic heart disease 6·1% (5·4–6·8)
2 Lower respiratory infections 10·8% (9·6–11·9) Diarrhoeal diseases 6·2% (5·3–7·3) Lower respiratory infections 6·1% (5·2–
7·0)
3 Preterm birth complications 7·1% (6·1–8·7) Preterm birth complications 5·6% (4·7–
6·8)
Preterm birth complications 4·9% (4·1–
6·0)
4 Congenital anomalies 4·8% (3·7–6·4) Ischaemic heart disease 5·2% (4·7–5·8) Diarrhoeal diseases 4·8% (4·0–5·7)
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1990 2005 2013
5 Ischaemic heart disease 3·6% (3·2–4·0) Congenital anomalies 4·1% (3·2–5·7) Congenital anomalies 4·1% (3·4–5)
6 Neonatal encephalopathy due to birth asphyxia 
and trauma 3·6% (2·8–4·5)
Neonatal encephalopathy due to birth 
asphyxia and trauma 3·8% (2·7–4·9)
Cerebrovascular disease 3·7% (3·2–4·2)
7 Cerebrovascular disease 2·8% (2·4–3·1) Cerebrovascular disease 3·3% (2·9–3·7) Low back and neck pain 3·6% (2·7–4·6)
8 Other neonatal disorders 2·5% (1·9–3·5) Low back and neck pain 2·9% (2·1–3·7) Neonatal encephalopathy due to birth 
asphyxia and trauma 3·5% (2·7–4·4)
9 Road injuries 2·3% (2·0–2·9) Road injuries 2·8% (2·6–3·1) Road injuries 3% (2·7–3·3)
10 Meningitis 2·2% (1·8–2·8) Iron-deficiency anaemia 2·2% (1·6–2·9) Diabetes mellitus 2·6% (2·4–3·0)
Data are proportion of DALYs out of all DALYs (95% uncertainty interval).
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Table 2
Top ten risk factors contributing to disability-adjusted life-years (DALYs) for the eastern 
Mediterranean region by sex; 1990, 2005, and 2013
1990 2005 2013
Males
1 Childhood undernutrition 15·8% (14·8–
16·6)
Childhood undernutrition 9·3% (8·5–9·9) High systolic blood pressure 7·9% (7·5–
8·2)
2 Unsafe water source 10·0% (8·4–11·2) High systolic blood pressure 6·5% (6·2–
6·7)
High body-mass index 7·0% (6·6–7·4)
3 Suboptimal breastfeeding 8·2% (6·2–10·2) Unsafe water source 6·1% (5·1–6·9) Childhood undernutrition 7·0% (6·4–7·5)
4 Unsafe sanitation 6·6% (5·8–7·3) High body-mass index 5·4% (5·0–5·8) Smoking 6·1% (5·7–6·5)
5 high systolic blood pressure4·2% (3·9–4·4 smoking 5·3% (4·9–5·5) High fasting plasma glucose 5·0% (4·7–
5·3)
6 No handwashing with soap 3·9% (3·1–4·6) Suboptimal breastfeeding 4·2% (3·0–5·4) Unsafe water source 4·9% (4·0–5·6)
7 Smoking 3·6% (3·3–3·8) High fasting plasma glucose 4·0% (3·7–
4·3)
Suboptimal breastfeeding 3·4% (2·4–4·3)
8 High body-mass index 3·4% (3·0–3·7) Unsafe sanitation 3·6% (3·1–4·0) Ambient particulate matter pollution 3·2% 
(3·2–3·3)
9 Household air pollution from solid fuels 
2·9% (2·5–3·2)
Ambient particulate matter pollution 2·9% 
(2·9–2·9)
High total cholesterol 2·9% (2·5–3·3)
10 Ambient particulate matter pollution 2·8% 
(2·7–2·8)
Household air pollution from solid fuels 
2·7% (2·4–3·1)
Diet high in sodium 2·8% (1·7–4·2)
Females
1 Childhood undernutrition 18·3% (17·3–
19·3)
Childhood undernutrition 10·9% (10·1–
11·5)
Childhood undernutrition 8·2% (7·6–8·6)
2 Unsafe water source 11·5% (9·6–13·0) Unsafe water source 6·8% (5·7–7·7) High body-mass index 8·1% (7·7–8·4)
3 Suboptimal breastfeeding 8·8% (6·6–11·1) High body-mass index 6·5% (6·2–6·8) High systolic blood pressure 7·5% (7·2–
7·9)
4 Unsafe sanitation 7·5% (6·6–8·3) High systolic blood pressure 6·5% (6·0–
6·7)
Unsafe water source 5·5% (4·6–6·3)
5 No handwashing with soap 4·5% (3·6–5·2) Suboptimal breastfeeding 4·5% (3·1–5·9) High fasting plasma glucose 5·0% (4·7–
5·2)
6 High systolic blood pressure 4·2% (3·9–
4·4)
High fasting plasma glucose 4·1% (3·8–
4·3)
Suboptimal breastfeeding 3·7% (2·5–4·7)
7 High body-mass index 4·0% (3·7–4·2) Unsafe sanitation 4·0% (3·5–4·5) Ambient particulate matter pollution 2·9% 
(2·9–3·0)
8 Household air pollution from solid fuels 
3·2% (2·8–3·6)
Household air pollution from solid fuels 
3·1% (2·8–3·4)
Household air pollution from solid fuels 
2·9% (2·6–3·2)
9 Ambient particulate matter pollution 2·8% 
(2·6–2·9)
Iron deficiency 2·8% (2·2–3·5) Iron deficiency 2·9% (2·3–3·6)
10 Iron deficiency 2·5% (2·0–3·2) Ambient particulate matter pollution 2·7% 
(2·7–2·8)
Unsafe sanitation 2·8% (2·4–3·2)
Total
1 Childhood undernutrition 17·0% (16·0–
17·6)
Childhood undernutrition 10·1% (9·5–
10·5)
High systolic blood pressure 7·7% (7·5–
7·9)
2 Unsafe water source 10·7% (9·1–11·9) High systolic blood pressure 6·5% (6·2–
6·6)
Childhood undernutrition 7·5% (7·1–7·8)
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1990 2005 2013
3 Suboptimal breastfeeding 8·5% (6·4–10·6) Unsafe water source 6·4% (5·5–7·1) High body-mass index 7·5% (7·2–7·8)
4 Unsafe sanitation 7·0% (6·2–7·7) High body-mass index 5·9% (5·6–6·3) Unsafe water source 5·2% (4·5–5·8)
5 High systolic blood pressure 4·2% (4·0–
4·4)
Suboptimal breastfeeding 4·3% (3·1–5·6) High fasting plasma glucose 5·0% (4·7–
5·2)
6 No handwashing with soap 4·2% (3·4–4·9) High fasting plasma glucose 4·0% (3·8–
4·2)
Smoking 3·9% (3·8–4·1)
7 High body-mass index 3·7% (3·3–3·9) Unsafe sanitation 3·8% (3·4–4·1) Suboptimal breastfeeding 3·5% (2·5–4·4)
8 Household air pollution from solid fuels 
3·0% (2·7–3·4)
Smoking 3·4% (3·2–3·5) Ambient particulate matter pollution 3·1% 
(3·1–3·1)
9 Ambient particulate matter pollution 2·8% 
(2·7–2·8)
Household air pollution from solid fuels 
2·9% (2·6–3·2)
Household air pollution from solid fuels 
2·7% (2·5–3·0)
10 High fasting plasma glucose 2·4% (2·2–
2·6)
Ambient particulate matter pollution 2·8% 
(2·8–2·8)
Diet high in sodium 2·7% (1·6–3·9)
Data are proportion of DALYs out of all DALYs (95% uncertainty interval).
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Table 3
Decomposition of the change of DALYs by cause into contributions from total population 
growth, population ageing, and changes in age-specific, sex-specific, and cause-specific 
DALY rates for the eastern Mediterranean region; 1990–2013
All causes Communicable, 
maternal, neonatal, and 
nutritional disorders
Non-communicable diseases Injuries
1990 DALYs, thousands  200 590 (190 173 
to 211 259)
  109 405 (103 984 to 113 
960)
  72 994 (64 276 to 81 552)   18 191 (16 233 to 
21 189)
DALYs expected with 2013 
population, 1990 population age 
structure, 1990 DALY rates, 
thousands
 341 549 (323 445 
to 359 991)
  187 154 (177 195 to 195 
919)
123 790 (108 708 to 138 813)   30 605 (27 404 to 
35 345)
DALYs expected with 2013 
population, 2013 population age 
structure, 1990 DALY rates, 
thousands
 300 382 (281 487 
to 319 833)
  141 736 (134 031 to 148 
771)
128 693 (113 087 to 144 394)   29 953 (26 530 to 
35 525)
2013 DALYs, thousands  206 831 (187 375 
to 226 886)
    73 251 (67 787 to 79 
600)
112 836 (98 705 to 128 394)   20 745 (18 617 to 
22 910)
Median percent change from 
1990 due to population growth
          70·3% (69·7 
to 70·7)
           71·1% (69·7 to 
72·3)
         69·4% (68·2 to 71·4)          68·3% (65·5 
to 70·6)
Median percent change from 
1990 due to population ageing
        –20·6% (–22·3 
to –18·8)
         –41·5% (–42·5 to –
40·5)
           6·9% (3·6 to 9·1)          –3·9% (–8·0 
to 1·9)
Median percent change from 
1990 due to change in DALY 
rates
        –46·6% (–51·4 
to –41·9)
         –62·6% (–66·7 to –
58·2)
       –21·8% (–31·1 to –12·5)        –50·3% (–65·1 
to –35·1)
Median percent change from 
1990 to 2013
            3·1% (–2·9 
to 8·7)
         –33·1% (–37·3 to –
28·5)
         54·5% (44·5 to 64·5)          14·3% (0·9 to 
28·6)
Data are median (95% CI). DALY=disability-adjusted life-year.
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